Every SEC Form 3/4/5 on record for this filer (CIK 1771961) — 3 issuers, 25 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | Chief Accounting Officer | 2023-03-10 → 2026-06-01 | 17 | −$414,814 |
| UBX | Unity Biotechnology, Inc. | See Remarks · lapsed | 2020-09-15 → 2020-09-15 | 2 | — |
| SNNA | Sienna Biopharmaceuticals, Inc. | Chief Financial Officer · lapsed | 2019-04-03 → 2019-10-04 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RCUS | 2026-06-01 | Sell | 2,562 | $25.77 | $66,023 | 39,581 |
| RCUS | 2025-12-18 | Sell | 4,343 | $22.25 | $96,632 | 18,531 |
| RCUS | 2025-12-17 | Sell | 2,113 | $22.16 | $46,824 | 22,874 |
| RCUS | 2025-12-16 | Sell | 2,376 | $21.88 | $51,987 | 24,987 |
| RCUS | 2025-11-26 | Sell | 1,900 | $26.00 | $49,400 | 27,363 |
| RCUS | 2025-09-29 | Sell | 2,831 | $13.00 | $36,803 | 27,363 |
| RCUS | 2025-09-05 | Sell | 1,579 | $11.88 | $18,759 | 30,194 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
